Results 71 to 80 of about 35,982 (269)

Polynomial Stabilization with Bounds on the Controller Coefficients∗∗##

open access: yesIFAC-PapersOnLine, 2015
Let b/a be a strictly proper reduced rational transfer function, with a monic. Consider the problem of designing a controller y/x, with deg(y) < deg(x) < deg(a) – 1 and x monic, subject to lower and upper bounds on the coefficients of y and x, so that the poles of the closed loop transfer function, that is the roots (zeros) of ax + by, are, if possible,
Eaton, J.   +3 more
openaire   +2 more sources

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Interpreting the effects of DNA polymerase variants at the structural level

open access: yesMolecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi   +7 more
wiley   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Coefficient Bounds for q-Noshiro Starlike Functions in Conic Region

open access: yesJournal of Function Spaces
We present and examine a new family of analytic functions that can be described by a q-Ruscheweyh differential operator. We discuss several novel results, including coefficient inequalities and other noteworthy properties such as partial sums and radii ...
V. Malathi, K. Vijaya
doaj   +1 more source

Ozaki-Type Bi-Close-to-Convex and Bi-Concave Functions Involving a Modified Caputo’s Fractional Operator Linked with a Three-Leaf Function

open access: yesFractal and Fractional
The focus of the present work is on the establishment and investigation of the coefficient estimates of two new subclasses of bi-close-to-convex functions and bi-concave functions; these are of an Ozaki type and involve a modified Caputo’s fractional ...
Kaliappan Vijaya   +4 more
doaj   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Coefficient bounds for q-convex functions related to q-Bernoulli numbers

open access: yesAnalele Stiintifice ale Universitatii Ovidius Constanta: Seria Matematica
The main objective of this paper is to present and investigate a subclass 𝒞(b, q) of q-convex functions in the unit disk that is defined by the q-Bernoulli numbers.
Breaz Daniel   +3 more
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy